Published in J Rheumatol on November 01, 1999
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis (2003) 1.31
The impact of rheumatic diseases on sexual function. Rheumatol Int (2009) 0.97
Health-related quality of life and employment among persons with systemic lupus erythematosus. Rheum Dis Clin North Am (2010) 0.95
Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis (2005) 0.94
Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations. Clin Rheumatol (2010) 0.90
Influence of social support on health-related quality of life in patients with systemic lupus erythematosus. Clin Rheumatol (2008) 0.88
The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol (2012) 0.83
Physical function assessment tools in pediatric rheumatology. Pediatr Rheumatol Online J (2008) 0.82
Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatology (Oxford) (2013) 0.81
Health care in systemic lupus erythematosus (SLE): the patient's perspective. Clin Rheumatol (2014) 0.78
Quality of life in patients with systemic lupus erythematosus (SLE) compared with related controls within a unique African American population. Lupus (2011) 0.76
Pattern of systemic lupus erythematosus in Egyptian patients: the impact of disease activity on the quality of life. Pan Afr Med J (2010) 0.76
Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives. Patient Prefer Adherence (2016) 0.75
Depression, Anxiety and Disease-Related Variables and Quality of Life Among Individuals With Systemic Lupus Erythematosus Living in Kermanshah Province, Iran. Iran Red Crescent Med J (2015) 0.75
Health status in SLE. J Rheumatol (2000) 0.75
Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. Patient Relat Outcome Meas (2017) 0.75
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 5.36
Style self-incompatibility gene products of Nicotiana alata are ribonucleases. Nature (1990) 4.75
Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum (1999) 4.46
Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet (1999) 3.92
Sequence variability of three alleles of the self-incompatibility gene of Nicotiana alata. Plant Cell (1989) 3.81
UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ (1995) 3.65
Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol (2001) 3.62
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol (1990) 3.58
Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ (1997) 3.51
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
A comparison of the reliability of self-reported drug use and sexual behaviors using computer-assisted versus face-to-face interviewing. AIDS Educ Prev (2000) 3.02
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum (1999) 2.99
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum (1995) 2.82
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75
Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol (1995) 2.69
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
Structural Analysis of Secreted Root Slime from Maize (Zea mays L.). Plant Physiol (1986) 2.46
Detection of legionellae in hospital water samples by quantitative real-time LightCycler PCR. Appl Environ Microbiol (2001) 2.43
A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J (1998) 2.43
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37
Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother (1972) 2.35
The effect of tobacco tax cuts on cigarette smoking in Canada. CMAJ (1997) 2.32
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31
Area-wide traffic calming for preventing traffic related injuries. Cochrane Database Syst Rev (2003) 2.31
Structural studies on the major component of Gladiolus style mucilage, an arabinogalactan-protein. Biochem J (1979) 2.28
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum (2000) 2.28
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Self-incompatibility: a self-recognition system in plants. Science (1990) 2.17
The role of continuous background infusions in patient-controlled epidural analgesia for labor and delivery. Anesth Analg (1994) 2.17
Breast cancer screening: the current position. BMJ (1991) 2.17
One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med (1997) 2.16
A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J Virol (1999) 2.12
The location of (1→3)-β-glucans in the walls of pollen tubes of Nicotiana alata using a (1→3)-β-glucan-specific monoclonal antibody. Planta (1991) 2.11
Mixed connective tissue disease--goodbye to all that. Br J Rheumatol (1992) 2.11
Disablement following stroke. Disabil Rehabil (1999) 2.10
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med (1988) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Proteinase inhibitors in Nicotiana alata stigmas are derived from a precursor protein which is processed into five homologous inhibitors. Plant Cell (1993) 2.03
Identification, isolation, and N-terminal sequencing of style glycoproteins associated with self-incompatibility in Nicotiana alata. Plant Cell (1989) 2.01
Inequalities in availability of National Health Service general dental practitioners in England and Wales. Br Dent J (2001) 2.00
The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus. J Rheumatol (1994) 1.98
Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) (2007) 1.97
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
The cell cycle genes cdc22+ and suc22+ of the fission yeast Schizosaccharomyces pombe encode the large and small subunits of ribonucleotide reductase. Mol Gen Genet (1993) 1.88
Traffic calming for the prevention of road traffic injuries: systematic review and meta-analysis. Inj Prev (2003) 1.85
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
A high proportion of hybridomas raised to a plant extract secrete antibody to arabinose or galactose. Plant Physiol (1984) 1.84
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci (2000) 1.77
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology (2005) 1.73
Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med (1998) 1.72
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Useful laboratory measurements in the management of systemic lupus erythematosus. Q J Med (1982) 1.68
From BILAG to BLIPS--disease activity assessment in lupus past, present and future. Lupus (2000) 1.68
Developing and testing a multimedia presentation of a health-state description. Med Decis Making (1995) 1.68
Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies? J Rheumatol (1996) 1.67
Localization of lectins in legume cotyledons. J Cell Sci (1975) 1.65
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum (2006) 1.65
Outcome after treatment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques. Eur Heart J (2003) 1.64
Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int (1995) 1.63
Self-incompatibility: how plants avoid illegitimate offspring. Proc Natl Acad Sci U S A (1994) 1.62
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis (2007) 1.62
Localization of the 26S proteasome during mitosis and meiosis in fission yeast. EMBO J (1998) 1.61
A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.61
Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables. Ultrasound Obstet Gynecol (2008) 1.61
A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) (1999) 1.60
Treatment adherence and clinical outcome in systemic lupus erythematosus. Rheumatology (Oxford) (2007) 1.59
Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. J Clin Invest (1985) 1.59
Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. Arch Intern Med (1998) 1.58
Living with lupus: a prospective pan-Canadian study. J Rheumatol (2001) 1.56
Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med (1998) 1.55
Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis (1987) 1.53
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Trainable rule-based algorithm for the measurement of joint space width in digital radiographic images of the knee. Med Phys (2000) 1.52
A (1-->3,1-->4)-beta-glucan-specific monoclonal antibody and its use in the quantitation and immunocytochemical location of (1-->3,1-->4)-beta-glucans. Plant J (1994) 1.51
Anaphylaxis: past, present and future. Allergy (2011) 1.50
The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. Br J Rheumatol (1995) 1.49
Peanut challenge: a retrospective study of 140 patients. Clin Exp Allergy (2001) 1.49
Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimens. J Clin Virol (2000) 1.49
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol (1995) 1.49
Prevalence, serological features, response to treatment and outcome of critical peripheral ischaemia in a cohort of lupus patients. Rheumatology (Oxford) (2008) 1.48
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum (1994) 1.48
Sjögren's syndrome: association with type-1 diabetes mellitus. Br J Rheumatol (1989) 1.48
Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum (1985) 1.48
Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) (2002) 1.47